Steve Blank

JUNE 19, 2014

clinical utility, customer, quality of data, reimbursement, what parts of the product are valuable, roles of CRO’s , and partners, etc.,) you make substantive changes to one or more parts of your initial business model, and this new data affects your biological and clinical hypotheses. The class is team based.

Lean 273

Lean SBIR Intellectual Property Customer Development 273

Steve Blank

AUGUST 21, 2013

What we found is that during the class almost all of them pivoted - making substantive changes to one or more of their business model canvas components. In the real world a big pivot in life sciences far down the road of development is a very bad sign due to huge sunk costs. Class starts Oct 1 st and runs through Dec 10 th.

SBIR 318

SBIR Technical Review Lean Startup 318

Steve Blank

DECEMBER 17, 2014

With that SBIR-Phase 1 funding the teams were trying to establish the technical merit, feasibility, and commercial potential of their technology. We’ve learned that information from 100 customers is just at the edge of having sufficient data to validate/invalidate a company’s business model hypotheses.

SBIR 268

SBIR Lean Video Customer Development 268